Steven Petrou
Fundador en PRAXIS PRECISION MEDICINES, INC. .
Cargos activos de Steven Petrou
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| PRAXIS PRECISION MEDICINES, INC. | Director Técnico/Científico/I+D | 01/01/2018 | - |
| Fundador | 22/09/2015 | - | |
RogCon, Inc.
 RogCon, Inc. Pharmaceuticals: MajorHealth Technology RogCon, Inc. engages in the discovery and development of novel treatments for SCN2A mutations that cause epilepsy, autism and other neurological disorders. The company was founded by Kelley Dalby, Steven Petrou and Alex Nemiroff and is headquartered in Miami Beach, FL. | Director Técnico/Científico/I+D | - | - |
| Fundador | - | - |
Historial de carrera de Steven Petrou
Antiguos cargos conocidos de Steven Petrou.
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
The Florey Institute of Neuroscience & Mental Health
 The Florey Institute of Neuroscience & Mental Health Miscellaneous Commercial ServicesCommercial Services The Florey Institute of Neuroscience & Mental Health operates as brain research center. Its teams work on a range of serious diseases including stroke, epilepsy, Alzheimer’s disease, Parkinson’s disease, multiple sclerosis, Huntington’s disease, motor neuron disease, traumatic brain and spinal cord injury, depression, schizophrenia, mental illness and addiction. The company was founded in July 2007 and is headquartered in Parkville, Australia. | Director/Miembro de la Junta | 01/07/2018 | 01/11/2022 |
| Corporate Officer/Principal | 01/07/2018 | 01/11/2022 |
Formación de Steven Petrou.
| University of Melbourne | Doctorate Degree |
Estadísticas
Internacional
| Estados Unidos | 3 |
| Australia | 3 |
Operativa
| Chief Tech/Sci/R&D Officer | 2 |
| Founder | 2 |
| Director/Board Member | 1 |
Sectorial
| Health Technology | 3 |
| Commercial Services | 2 |
| Consumer Services | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| PRAXIS PRECISION MEDICINES, INC. | Health Technology |
| Empresas privadas | 2 |
|---|---|
RogCon, Inc.
RogCon, Inc. Pharmaceuticals: MajorHealth Technology RogCon, Inc. engages in the discovery and development of novel treatments for SCN2A mutations that cause epilepsy, autism and other neurological disorders. The company was founded by Kelley Dalby, Steven Petrou and Alex Nemiroff and is headquartered in Miami Beach, FL. | Health Technology |
The Florey Institute of Neuroscience & Mental Health
The Florey Institute of Neuroscience & Mental Health Miscellaneous Commercial ServicesCommercial Services The Florey Institute of Neuroscience & Mental Health operates as brain research center. Its teams work on a range of serious diseases including stroke, epilepsy, Alzheimer’s disease, Parkinson’s disease, multiple sclerosis, Huntington’s disease, motor neuron disease, traumatic brain and spinal cord injury, depression, schizophrenia, mental illness and addiction. The company was founded in July 2007 and is headquartered in Parkville, Australia. | Commercial Services |
- Bolsa de valores
- Insiders
- Steven Petrou
- Experiencia
